Tempest Therapeutics earnings were -$41.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TPST earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$13.8M, up 30.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TPST reported annual earnings of -$41.8M, with 41.9% growth. The next TPST earnings date is May 7, 2025.
Tempest Therapeutics Earnings Reports & History FAQ
What were Tempest Therapeutics's earnings last quarter?
On TPST's earnings call on Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q4 2024 earnings per share (EPS) of -$0.31, up 8.82% year over year. Total TPST earnings for the quarter were -$13.81 million. In the same quarter last year, Tempest Therapeutics's earnings per share (EPS) was -$0.34.
The next TPST earnings call is Invalid Date. Add TPST to your watchlist to be reminded of Tempest Therapeutics's next earnings date.
What was TPST's earnings growth in the past year?
As of Tempest Therapeutics's earnings date in Invalid Date, Tempest Therapeutics's earnings has grown year over year. TPST earnings in the past year totalled -$41.84 million.
Is Tempest Therapeutics profitable or losing money?
As of the last Tempest Therapeutics earnings report, Tempest Therapeutics is currently losing money. Tempest Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$41.84 million, a 41.88% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.